Trial intelligence / Profile preview

Wound Infiltration vs Intrathecal Morphine for C-Section Analgesia

NCT02279628Phase 4Unknown

Sponsor
CHRU de Nancy - Hôpital Central
Start
Jul 2014
Primary completion
Dec 2016
Modality
Targeted Liposomes, Stealth (PEGylated) Liposomes, Conventional Liposomes
Countries
1
01

Overview

A Phase 4 trial of ropivacaine hydrochloride liposomal suspension injection in postoperative pain, sponsored by CHRU de Nancy - Hôpital Central. Status: unknown.

02

Drugs

ropivacaine hydrochloride liposomal suspension injection
03

Conditions

postoperative pain

Beyond the preview

Go deeper on NCT02279628.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02279628.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call